Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report

Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e21-e24. doi: 10.1016/j.clml.2020.08.019. Epub 2020 Sep 17.
No abstract available

Keywords: Daratumumab; Hyperviscosity syndrome; IgM; Multiple myeloma; Plasmapheresis.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Blood Viscosity / drug effects*
  • Female
  • Humans
  • Middle Aged
  • Multiple Myeloma / drug therapy*

Substances

  • Antibodies, Monoclonal
  • daratumumab